新型药片应用在减少儿科心脏骤停期间指导偏差的有效性:一项随机临床试验
Francesco Corazza1, Marta Arpone2, Giacomo Tardini2
1Pediatric Emergency Division, Department of Women's and Children's Health, University Hospital of Padova, Padova, Italy.
JAMA network open
|August 3, 2023
概括
在模拟儿科心脏骤停期间,PediAppREST应用程序显著减少了指导方针偏差,提高了团队的表现. 这种工具增强了重症儿童的复苏工作.
科学领域:
- 儿科急救医学 儿科急救医学
- 临床复苏科学 临床复苏科学
- 医疗信息学 医疗信息学
背景情况:
- 偏离国际复苏指南在儿科心脏骤停管理中很常见.
- 这些偏差会对重症儿童的临床结果产生负面影响.
- 一个新的交互式平板电脑应用程序PediAppREST被开发来解决这个问题.
研究的目的:
- 评估PediAppREST应用程序在改善儿科心脏骤停管理方面的有效性.
- 评估应用程序对在模拟医院环境中遵守复苏指南的影响.
主要方法:
- 一个多中心,三组,基于模拟的随机临床试验,涉及100个团队.
- 参与者包括儿科,急诊医学和麻醉学的住院医生.
- 干预措施:PediAppRREST应用程序,纸质的儿科高级生命支持 (PALS) 卡,或没有认知辅助.
主要成果:
- 与两个对照组相比,PediAppRREST组显示出与复苏指南的偏差明显较少 (P < .001).
- 临床性能工具的得分在PediAppREST组与对照组相比显著更高 (P = .002对照. PALS;P=0.01与没有援助).
- 没有观察到胸部压缩质量或感知工作负载的显著差异.
结论:
- PediAppRREST应用程序有效地减少了模拟儿科心脏骤停期间的指导方针偏差.
- 使用PediAppRREST可以提高整体团队在复苏场景中的临床表现.
- 这项技术有望提高儿科紧急情况期间的护理质量.
相关概念视频
Cardiopulmonary Resuscitation III: AED Use
38
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
38
Cardiopulmonary Resuscitation IV: Pharmacological Management
22
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
22
Drug Delivery: Enteral Route
505
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
505
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K


